BRATICA JOSEPH (Principal Financial Officer) sold 12.6% of their position (1.13K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $174.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/5/2020ACC: 0001209191-20-045321
Officer· Principal Financial Officer
Since Aug 2020
-1.13K
Net shares
Net seller
$174.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.13K acquired · 2.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.13K
Price / share
$29.60
Trade value
$33.30K
% of position
14.4%
8/3/2020
7.83K→8.96K
Common Stock
Direct
Shares
−1.13K
Price / share
$155.00
Trade value
$174.38K
% of position
12.6%
8/3/2020
8.96K→7.83K
Total
Net shares
+0.00
Net value
-$141.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2020 | M · Option Exercise | +1.13K | $29.60 | $33.30K | 14.4% | 7.83K | 8.96K |
| Common Stock Direct | 8/3/2020 | S · Sale | −1.13K | $155.00 | $174.38K | 12.6% | 8.96K | 7.83K |
| Total | +0.00 | -$141.07K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.13K shares
Shares
−1.13K
Strike price
29.60
Held after
5.63K
Exercisable
—
8/3/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.13K shares | 8/3/2020 | M · Option Exercise | −1.13K | 29.60 | — | 5.63K |